Q4 2013
Released Mar 27, 2014, after the close
10-K filed Mar 27, 2014, 86 days after period end · 0001144204-14-018406
Q4 2013 · 10-K
Revenue$9.60M$9.60M +5.8% vs Q4 2012+61.4% vs Q3 2013
Net Income$597.00K$597.00K +31.8% vs Q4 2012−51.7% vs Q3 2013
EPS Diluted$0.04$0.04 ±0.0% vs Q4 2012−50.0% vs Q3 2013
Gross Profit$6,587,000+15.8%
Operating Incomederived$602,000+33.5%
Operating Cash Flowderived$856,000N/M
Free Cash Flowderived$738,000N/M
Margins · derived
Gross margin68.6%+6.0 pt vs Q4 2012
Operating margin6.3%+1.3 pt vs Q4 2012
Net margin6.2%+1.2 pt vs Q4 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $9.60M | $9.08M | $7.46M | — |
| Net Income | $597.00K | $453.00K | -$1.83M | — |
| EPS Diluted | $0.04 | $0.04 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR